Headquartered in Saint Louis, MO Fiscal year ends December NYSE: CNC centene.com
Centene Corporation is a Fortune 500 healthcare enterprise providing fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, with a focus on under-insured individuals. The company operates across Medicaid, Medicare (including Medicare Advantage, Medicare Prescription Drug Plans, and Medicare Supplement), and Commercial (Marketplace and individual/group) lines of business, serving more than 1 in 15 individuals across the United States. Centene's Medicaid business is its largest segment with approximately 11.9 million members, while its rapidly growing Medicare PDP business serves approximately 8.9 million members. The Commercial segment includes Health Insurance Marketplace products as well as individual and commercial group offerings. The company takes a localized approach with regional teams and administers state-directed and pass-through payments as part of its managed care operations. Centene is currently executing an enterprise optimization program involving workforce restructuring and vendor cost management to improve operating efficiency and margin trajectory. Updated
Centene reports at 6:00 AM ET with four straight EPS beats behind it, and the bar this quarter sits at just $0.0972 on $46.95 billion in revenue. The guidance on Medicaid cuts and 2027 Medicare Advantage rates is what moves the $33.6 billion stock.
More than 4.6 million Americans left the individual health insurance market in a single year. New research from KFF shows enrollment fell 18%, from 25.2 million in June 2025 to 20.5 million…
On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH | UNH Price Prediction): “If you have…
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
Pre-Market Stock Futures: Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday. We may start to see some end-of-the-quarter…
Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation…
When Centene Corporation reported its first-quarter results in late April, the numbers told two stories that seemed impossible to reconcile. The St. Louis-based insurer had hemorrhaged customers, watching its Affordable Care Act…
Don Lair Shares of Centene Corporation (NYSE: CNC | CNC Price Prediction) have climbed 6.2% from their November 10 low of $34.25. Today, shares closed at $36.38. The move coincides with sustained bullish sentiment…
Douglas A. McIntyre Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, family, and small group plans, primarily through Affordable Care Act (ACA) exchanges. Its platform leverages…
The abrupt departure of UnitedHealth (NYSE:UNH) CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector. Investors in UNH stock have certainly had plenty of headwinds to deal with over…
Michael Burry is best-known as the billionaire investor who correctly predicted the housing market crash in 2007 that was detailed in the book, The Big Short. It was subsequently made into a…
Analysts' first ratings changes for 2024 include some deletions from a top buy list and a downgrade for Apple.
Wednesday's top analyst upgrades and downgrades included American Express, Catalent, Centene, Lowe's Companies, NetApp, Shoals Technologies, Valley National Bancorp and ZoomInfo Technologies.
Thursday's top analyst upgrades and downgrades included Best Buy, Carnival, Caterpillar, Centene, ChargePoint, Foot Locker, Hewlett Packard Enterprise, Palo Alto Networks, PDD, Peloton Interactive, Realty Income, Sunrun, Texas Instruments and UDR.
Wednesday's top analyst upgrades and downgrades included Allstate, Archer Daniels Midland, Avis Budget, Baidu, Centene, Lemonade, Melco Resorts & Entertainment, Palantir Technologies, Peabody Energy, Philip Morris, Shopify and Zscaler.
Here are our previews of BP, Centene, Linde, which will report earnings before U.S. markets open on Tuesday.
Centene Corporation is a Fortune 500 healthcare enterprise providing fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, with a focus on under-insured individuals.
The Wall Street consensus 12-month price target for CNC is $71.78. CNC price prediction →
